_____________________________________________________________________________________________________ # Assistant Professor; ≡ Professor & Head of Department; ⱷ Associate Professor & HOU; † Lecturer & Research Scholar; *Corresponding author: E-mail: kalgish86@gmail.com; Journal of Advances in Medicine and Medical Research 34(1): 65-72, 2022; Article no.JAMMR.82386 ISSN: 2456-8899 (Past name: British Journal of Medicine and Medical Research, Past ISSN: 2231-0614, NLM ID: 101570965) A Study of Safety and Effectiveness of Intra Venous Iron Sucrose Therapy in Pregnant Women Suffering From Moderate to Severe Iron Deficiency Anaemia Disease Heena Rajput a# , Kinnari Amin a# , Bhamini Kadikar a# , Nilesh Shah a≡ , Kalgi Shah b*ⱷ and Ishan Shah a† a Department of Obstetrics and Gynaecology, Nootan Medical College & Research Centre, Visnagar, Gujarat, India. b Department of Medicine, Nootan Medical College & Research Centre, Visnagar, Gujarat, India. Authors’ contributions This work was carried out in collaboration among all authors. All authors read and approved the final manuscript. Article Information DOI: 10.9734/JAMMR/2022/v34i131249 Open Peer Review History: This journal follows the Advanced Open Peer Review policy. Identity of the Reviewers, Editor(s) and additional Reviewers, peer review comments, different versions of the manuscript, comments of the editors, etc are available here: https://www.sdiarticle5.com/review-history/82386 Received 09 November 2021 Accepted 12 January 2022 Published 15 January 2022 ABSTRACT Aims & Objectives: To determine the effectiveness and safety of IV Iron sucrose therapy in antenatal women with moderate to severe Iron deficiency anaemia. Methodology: It is a retrospective study with secondary data analysis. We have analyzed the data collected from January 2019 to December 2019 at the Nootan general hospital, Visnagar, Gujarat, India. Analysis of antenatal women with moderate to severe anaemia (Hb 6 to 8gm%) in the second trimester and early third trimester(20 to 34weeks of gestation) are done during their routine antenatal care who were prescribed Intravenous Iron sucrose in a standard-dose of 1000 mg given as 200 mg on alternate days after confirming the iron deficiency anaemia. Effectiveness of the therapy has been studied by comparing the Hb level at the point baseline where start of the treatment and 4 week or more after the last treatment was given (endline). The safety profile of the Original Research Article